145 related articles for article (PubMed ID: 31196636)
1. Bile Acids in Cholestasis and its Treatment.
Pablo Arab J; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16 Suppl 1():S53-S57. PubMed ID: 31196636
[TBL] [Abstract][Full Text] [Related]
2. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
3. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
Cabrera D; Arab JP; Arrese M
Handb Exp Pharmacol; 2019; 256():237-264. PubMed ID: 31236688
[TBL] [Abstract][Full Text] [Related]
4. From blood to bile: recent advances in hepatobiliary transport.
Arrese M; Accatino L
Ann Hepatol; 2002; 1(2):64-71. PubMed ID: 15115970
[TBL] [Abstract][Full Text] [Related]
5. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
7. Targeting FXR in Cholestasis.
Keitel V; Dröge C; Häussinger D
Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
[TBL] [Abstract][Full Text] [Related]
8. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.
Beuers U; Trauner M; Jansen P; Poupon R
J Hepatol; 2015 Apr; 62(1 Suppl):S25-37. PubMed ID: 25920087
[TBL] [Abstract][Full Text] [Related]
9. Bile acid interactions with cholangiocytes.
Xia X; Francis H; Glaser S; Alpini G; LeSage G
World J Gastroenterol; 2006 Jun; 12(22):3553-63. PubMed ID: 16773712
[TBL] [Abstract][Full Text] [Related]
10. [Effect of geniposidic acid on hepato-enteric circulation in cholestasis rats through Sirt1-FXR signaling pathway].
Chen H; Li J; Hu L; Zhao W; Yu H; Liu HZ; Ma ST
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):787-795. PubMed ID: 30989893
[TBL] [Abstract][Full Text] [Related]
11. New therapies target the toxic consequences of cholestatic liver disease.
Jansen PLM
Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):277-285. PubMed ID: 29310470
[TBL] [Abstract][Full Text] [Related]
12. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
[TBL] [Abstract][Full Text] [Related]
13. Fibrates and cholestasis.
Ghonem NS; Assis DN; Boyer JL
Hepatology; 2015 Aug; 62(2):635-43. PubMed ID: 25678132
[TBL] [Abstract][Full Text] [Related]
14. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis.
Hruz P; Zimmermann C; Gutmann H; Degen L; Beuers U; Terracciano L; Drewe J; Beglinger C
Gut; 2006 Mar; 55(3):395-402. PubMed ID: 16150853
[TBL] [Abstract][Full Text] [Related]
15. Bile acid transporters: structure, function, regulation and pathophysiological implications.
Alrefai WA; Gill RK
Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
[TBL] [Abstract][Full Text] [Related]
16. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
17. The role of bile acids in cholestatic liver injury.
Cai SY; Boyer JL
Ann Transl Med; 2021 Apr; 9(8):737. PubMed ID: 33987435
[TBL] [Abstract][Full Text] [Related]
18. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of cholestasis.
Zollner G; Trauner M
Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
